Research Article
MicroRNA-7 as a Potential Biomarker for Prognosis in Pancreatic Cancer
Table 1
The relationship between miR-7 expression and clinicopathologic characteristics in pancreatic cancer patients.
| Clinicopathologic variable | miR-7 | value | Low expression | High expression |
| Age (y) | | | 0.637 | ≤50 | 7 | 11 | | >50 | 30 | 52 | | Gender | | | 0.855 | Female | 12 | 25 | | Male | 25 | 38 | | Tumor size (cm)[a] | | | 0.645 | ≤2 | 0 | 2 | | >2 | 37 | 59 | | Tumor differentiation | | | 0.015 | Well/moderate | 19 | 49 | | Poor | 18 | 14 | | TNM stage[b] | | | 0.028 | I+II | 35 | 62 | | III+IV | 2 | 0 | | Lymph node metastasis[c] | | | 0.930 | Negative | 20 | 31 | | Positive | 15 | 24 | | Distant metastasis | | | 0.011 | Negative | 35 | 63 | | Positive | 2 | 0 | | Lymphovascular invasion | | | 0.875 | Absent | 21 | 37 | | Present | 16 | 26 | |
|
|
Statistically significant ( ). [a]2 patients’ information missing; [b]1 patient’s information missing; [c]10 patients’ information missing. |